Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127406161 | 12740616 | 1 | I | 20160818 | 20160914 | 20160914 | PER | US-ASTRAZENECA-2016SE89470 | ASTRAZENECA | 0.00 | F | Y | 0.00000 | 20160914 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127406161 | 12740616 | 1 | PS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | U | 19810 | ||||||||||
| 127406161 | 12740616 | 2 | SS | JAKAFI | RUXOLITINIB | 1 | Oral | 10.0MG UNKNOWN | 0 | 10 | MG | TABLET | |||||||
| 127406161 | 12740616 | 3 | SS | JAKAFI | RUXOLITINIB | 1 | Oral | 15.0MG UNKNOWN | 0 | 15 | MG | TABLET | |||||||
| 127406161 | 12740616 | 4 | SS | JAKAFI | RUXOLITINIB | 1 | Oral | 20.0MG UNKNOWN | 1403293BB | 0 | 20 | MG | TABLET | BID | |||||
| 127406161 | 12740616 | 5 | C | ASCORBIC ACID. | ASCORBIC ACID | 1 | 0 | ||||||||||||
| 127406161 | 12740616 | 6 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 | ||||||||||||
| 127406161 | 12740616 | 7 | C | RETINOL | RETINOL | 1 | 0 | ||||||||||||
| 127406161 | 12740616 | 8 | C | ERGOCALCIFEROL. | ERGOCALCIFEROL | 1 | 0 | ||||||||||||
| 127406161 | 12740616 | 9 | C | TOCOPHEROL | TOCOPHEROL | 1 | 0 | ||||||||||||
| 127406161 | 12740616 | 10 | C | GLUCOSAMINE | GLUCOSAMINE | 1 | 0 | ||||||||||||
| 127406161 | 12740616 | 11 | C | PROCRIT | ERYTHROPOIETIN | 1 | 0 | ||||||||||||
| 127406161 | 12740616 | 12 | C | THYROID MEDICATION | UNSPECIFIED INGREDIENT | 1 | 0 | ||||||||||||
| 127406161 | 12740616 | 13 | C | NAUSEA MEDIACTION | 2 | 0 | |||||||||||||
| 127406161 | 12740616 | 14 | C | CHEMOTHERAPY | UNSPECIFIED INGREDIENT | 1 | 0 | ||||||||||||
| 127406161 | 12740616 | 15 | C | VITAMIN B NOS | VITAMIN B | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127406161 | 12740616 | 2 | Splenomegaly |
| 127406161 | 12740616 | 3 | Splenomegaly |
| 127406161 | 12740616 | 4 | Splenomegaly |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127406161 | 12740616 | Diarrhoea | |
| 127406161 | 12740616 | Splenomegaly |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |